CCDC169 anticorps (Cy5)

N° du produit ABIN1421520

Détail du produit anti-CCDC169 anticorps (Cy5)

Antigène: CCDC169 (Coiled-Coil Domain Containing 169 (CCDC169))

Reactivité: Humain, Souris, Rat

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp CCDC169 est conjugé à/à la Cy5

Application: Western Blotting (WB), Immunofluorescence (Paraffin-embedded Sections) (IF (p))

Réactivité croisée: Humain, Souris, Rat

Purification: Purified by Protein A.

Immunogène: KLH conjugated synthetic peptide derived from human C13orf38

Isotype: IgG

Information d'application

Indications d'application: IF(IHC-P) 1:50-200

Restrictions: For Research Use only

Stockage

Format: Liquid

Concentration: 1 μg/μL

Buffer: Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.

Agent conservateur: ProClin

Précaution d'utilisation: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.

Stock: -20 °C

Stockage commentaire: Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.

Date de péremption: 12 months

Détails sur CCDC169

Antigène: CCDC169 (Coiled-Coil Domain Containing 169 (CCDC169))

Autre désignation: C13orf38 (CCDC169 Produits)

Synonymes: anticorps C13orf38, anticorps A730037C10Rik, anticorps c13orf38, anticorps coiled-coil domain containing 169, anticorps coiled-coil domain containing 169 S homeolog, anticorps CCDC169, anticorps Ccdc169, anticorps ccdc169.S

Sujet:

Synonyms: FLJ57222, Chromosome 13 open reading frame 38, CM038_HUMAN, FLJ13506, FLJ29024, Hypothetical protein LOC728591, RP11-251J8.1, UPF0594 protein C13orf38.

Background: Comprising nearly 4 % of human DNA, chromosome 13 contains around 114 million base pairs and 400 genes. Key tumor suppressor genes on chromosome 13 include the breast cancer susceptibility gene, BRCA2, and the RB1 (retinoblastoma) gene. RB1 encodes a crucial tumor suppressor protein which, when defective, leads to malignant growth in the retina and has been implicated in a variety of other cancers. The gene SLITRK1, which is associated with Tourette syndrome, is on chromosome 13. As with most chromosomes, polysomy of part or all of chromosome 13 is deleterious to development and decreases the odds of survival. Trisomy 13, also known as Patau syndrome, is quite deadly and the few who survive past one year suffer from permanent neurologic defects, difficulty eating and vulnerability to serious respiratory infections. The LOC728591 gene product has been provisionally designated LOC728591 pending further characterization.